Capacity strengthening through pre-migration tuberculosis screening programmes: IRHWG experiences

International Journal of Tuberculosis and Lung Disease

Volumn 21, Issue 7, 2017, Pages 737-745

  Douglas, P ^a   Posey, D L ^b   Zenner, D ^c   Robson, J ^d   Abubakar, I ^c   Giovinazzo, G ^e  

^a Diabetes Australia NSW   (Australia)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d Service Design and Performance   (New Zealand)

^e Refugees and Citizenship Canada   (Canada)

Author keywords

Capacity building; Intergovernmental; Migration; Population health

Indexed keywords

ISONIAZID;

ARTICLE; ASIA; AUSTRALIA; CANADA; CHINA; DISEASE CONTROL; DISEASE ELIMINATION; HEALTH CARE COST; HEALTH CARE PERSONNEL; HEALTH DISPARITY; HEALTH PROMOTION; HEALTH SERVICE; HUMAN; IMMIGRATION; INCIDENCE; INDIA; LABORATORY TEST; MIGRANT; NEW ZEALAND; PRE-MIGRATION MEDICAL SCREENING; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; REFUGEE; SCREENING TEST; TUBERCULOSIS; UNITED KINGDOM; UNITED STATES; CAPACITY BUILDING; GLOBAL HEALTH; HEALTH CARE DELIVERY; INTERNATIONAL COOPERATION; LABORATORY; MASS SCREENING; MIGRATION; ORGANIZATION AND MANAGEMENT; PROCEDURES; PUBLIC HEALTH;

CAPACITY BUILDING; DELIVERY OF HEALTH CARE; EMIGRATION AND IMMIGRATION; GLOBAL HEALTH; HUMANS; INTERNATIONAL COOPERATION; LABORATORIES; MASS SCREENING; NATIONAL HEALTH PROGRAMS; PUBLIC HEALTH; REFUGEES; TRANSIENTS AND MIGRANTS; TUBERCULOSIS;

EID: 85018891405     PISSN: 10273719     EISSN: 18157920     Source Type: Journal    
DOI: 10.5588/ijtld.17.0019     Document Type: Article

References (48)

1. Dara M, Gushulak B D, Posey D L, Zellweger J P, Migliori G B. The history and evolution of immigration medical screening for tuberculosis. Expert Rev Anti Infect Ther 2013; 11: 137-146.
2. Severi E, Maguire H, Ihekweazu C, Bickler G, Abubakar I. Outcomes analysis of new entrant screening for active tuberculosis in Heathrow and Gatwick airports, United Kingdom 2009/2010. BMC Infect Dis 2016; 16: 178.
3. Muzyamba M, Aldridge R, Ekeke N, Abubakar I, Zenner D. UK pre-entry tuberculosis screening brief report 2013. London, UK: Gov.UK, 2013.
4. United States Government. Medical Examination of Aliens- Revisions to Medical Screening Process. Washington DC, USA: US Government, 2016. Final Rule Federal Register 2016; 81: 4191-4206. https://www.gpo.gov/fdsys/pkg/FR-2016-01-26/pdf/2016-01418.pdf Accessed April 2017.
5. Gov.UK. Tuberculosis: pre-entry screening in the UK. London, UK: Gov.UK, 2017. https://www.gov.uk/government/publications/tuberculosis-pre-entry-screening-in-The-uk. Accessed April 2017.
6. Government of Canada. Immigration and Refugee Protection Act (SC 2001, c. 27). Ottawa, ON, Canada: Government of Canada, 2001. http://laws.justice.gc.ca/eng/acts/i-2.5/. Accessed April 2017.
7. Immigration New Zealand. New Zealand Operations Manual. Wellington, New Zealand: INZ, 2017. http://onlineservices.immigration.govt.nz/opsmanual/?-ga1.193272997.983730666.1441326118. Accessed April 2017.
8. Government of Australia. Australia Migration Regulations 1994-Schedule 4. Canberra, ACT, Australia: Government of Australia, 1994. http://www.austlii.edu.au/au/legis/cth/consol-reg/mr1994227/sch4.html. Accessed April 2017.
9. United States Department of Homeland Security. Yearbook of Immigration Statistics: 2014. Washington, DC, USA: US Department of Homeland Security, Office of Immigration Statistics, 2016.
10. Public Health England. Tuberculosis in England 2016 Report. London, UK: PHE, 2015. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/492431/TB-Annual-Report-v2.6-07012016.pdf Accessed April 2017.
11. White Z A, Painter J, Douglas P, et al. Immigrant arrival and TB trends among large immigrant and refugee receiving countries 2005-2009. Tuberculosis Research and Treatment 2017, Article ID 8567893. https://www.hindawi.com/journals/trt/2017/8567893/Accessed April 2017.
12. World Health Organization. Global tuberculosis report, 2016. WHO/HTM/TB/2016.13. Geneva, Switzerland: WHO, 2016. http://www.who.int/tb/publications/global-report/en/. Accessed April 2017.
13. Centers for Disease Control and Preventions. Technical instructions for panel physicians. Atlanta, GA, USA: CDC, 2017. http://www.cdc.gov/immigrantrefugeehealth/exams/ti/panel/technical-instructions-panel-physicians.html. Accessed April 2017.
14. Australian Government, Department of Immigration and Border Protection. Australia's Panel Physician Instructions. Canberra, ACT, Australia: Australian Government, 2016. https://www.border.gov.au/Panelphysician-s/Documents/panelmember-instructions.pdf Accessed April 2017.
15. Gov.UK. Tuberculosis technical instructions. London, UK: Gov. UK, 2013. https://www.gov.uk/government/publications/uktuberculosis-Technical-instructions. Accessed April 2017.
16. Immigration New Zealand. New Zealand panel physician instructions. Wellington, New Zealand: INZ, 2017. https://www.immigration.govt.nz/assist-migrants-And-students/otherindustry-partners/medical-professionals/panel-physicianinstructions. Accessed April 2017.
17. Immigration and Refugee Health Working Group. Considerations for technical specifications on tuberculosis screening and treatment: IRHWG internal document. Geneva, Switzerland: International Organization for Migration, 2016.
18. Nahid P, Dorman S E, Alipanah N, et al. Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of drug-susceptible tuberculosis. Clin Infect Dis 2016; 63: E147-e195. http://cid.oxfordjournals.org/content/63/7/e147. Accessed April 2017.
19. Posey D L, Naughton M P, Willacy E A, et al. Implementation of new TB screening requirements for U.S.-bound immigrants and refugees, 2007-2014. MMWR Morb Mortal Wkly Rep 2014; 63: 234-236.
20. Liu Y, Posey D L, Cetron M S, Painter J A. Effect of a culturebased screening algorithm on tuberculosis incidence in immigrants and refugees bound for the United States: A population-based cross-sectional study. Ann Intern Med 2015; 162: 420-428.
21. Toms C, Stapledon R, Waring J, Douglas P, and the National Tuberculosis Advisory Committee. Tuberculosis notifications in Australia, 2012 and 2013. Commun Dis Intell Q Rep 2015; 39: E217-E235.
22. Public Health England. UK pre-entry tuberculosis screening report 2015. London, UK: PHE, 2015. https://www.gov.uk/government/uploads/system/uploads/attachment-data/file/555150/UK-pre-entry-Tuberculosis-screening-2015-GTW230916.pdf. Accessed April 2017.
23. Aldridge R W, Zenner D, White P J, et al. Tuberculosis in migrants moving from high-incidence to low-incidence countries: A population-based cohort study of 519, 955 migrants screened before entry to England, Wales, and Northern Ireland. Lancet 2016; 388: 2510-2518.
24. Institute of Environmental Science and Research Ltd. Tuberculosis in New Zealand: Annual Report 2014. Porirua, New Zealand: ESR, 2015.
25. Cain K P, Marano N, Kamene M, et al. The movement of multidrug-resistant tuberculosis across borders in East Africa needs a regional and global solution. PLOS Med 2015; 12: E1001791.
26. Moore B K, Posey D L, Maloney S A, Cetron M, Castro K. Tackling tuberculosis abroad: The key to TB elimination in the United States. A report CSIS Global Health Policy Center. Washington DC, USA: Center for Strategic and International Studies, 2014.
27. Schwartzman K, Oxlade O, Barr R G, et al. Domestic returns from investment in the control of tuberculosis in other countries. N Engl J Me 2005; 353: 10081020.
28. United Nations, Department of Economic and Social Affairs, Population Division. International migration report 2015: highlights. New York, NY, USA: UN, 2016.
29. World Health Organization. The end TB strategy. Geneva, Switzerland: WHO, 2014. http://www.who.int/tb/strategy/End-TB-Strategy.pdf?ua1. Accessed April 2017.
30. European Centre for Disease Prevention and Control. Multidrug-resistant tuberculosis in migrants, multi-country cluster. Stockholm, Sweden: ECDC, 2016.
31. Zimmerman C, Kiss L, Hossain M. Migration and health: A framework for 21st century policy-making. PLOS Med 2011: 8: E1001034.
32. Abarca Tomas B, Pell C, Bueno Cavanillas A, Guillen Solvas J, Pool R, Roura M. Tuberculosis in migrant populations. A systematic review of the qualitative literature. PLOS ONE 2013; 8: E82440.
33. Gushalak B D, MacPherson D W. Health aspects of the predeparture phase of migration. PLOS Med 2011; 8: E1001035.
34. Wickramage K, Mosca D. Can migration health assessments become a mechanism for global public health good? Int J Environ Res Public Health 2014; 11: 9954-9963.
35. Dhavan P, Mosca D. Tuberculosis and migration: A post 2015 call to action. Migration Policy Practice 2014; 4: 17-22.
36. Gushalak B D, MacPherson D W. The basic principles of migration health: population mobility and gaps in disease prevalence. Emerg Themes Epidemiol 2006; 3: 3.
37. Littleton J, Park J, Thornley C, Anderson A, Lawrence J. Migrants and tuberculosis: Analysing epidemiological data with ethnography. Aust NZ J Public Health 2008; 32: 142-149.
38. Falzon D, Zignol M, Migliori G B, Nunn P, Raviglione M C. Migration: An opportunity for the improved management of tuberculosis worldwide. Italian J Public Health 2012; 9: 1-11.
39. Zenner D, Southern J, van Hest R, et al. Active case finding for tuberculosis among high-risk groups in low-incidence countries. Int J Tuberc Lung Dis 2013; 17: 573-582.
40. Uplekar M, Creswell J, Ottmani S E, Weil D, Sahu S, Lönnroth K. Programmatic approaches to screening for active tuberculosis. Int J Tuberc Lung Dis 2013; 17: 1248-1256.
41. Aldridge R W, Yates T A, Zenner D, White P J, Abubakar I, Hayward A C. Pre-entry screening programmes for tuberculosis in migrants to low-incidence countries: A systematic review and meta-Analysis. Lancet Infect Dis 2014; 14: 1240-1249.
42. Alvarez G G, Gushulak B, Abu Rumman K, et al. A comparative examination of tuberculosis immigration medical screening programs from selected countries with high immigration and low tuberculosis incidence rates. BMC Infect Dis 2011; 11: 3.
43. World Health Organization. Systematic screening for active tuberculosis: principles and recommendations. WHO/HTM/TB/2013.04. Geneva, Switzerland: WHO, 2013. http://apps.who.int/iris/bitstream/10665/84971/1/9789241548601-eng.pdf?ua1. Accessed April 2017.
44. Paglia M G. Bevilacqua N, Haji H S, et al. Improvement of tuberculosis laboratory capacity on Pemba Island, Zanzibar: A health cooperation project. PLOS ONE 2012; 7: E44109.
45. Atre S. An urgent need for building technical capacity for rapid diagnosis of multidrug-resistant tuberculosis (MDR-TB) among new cases: A case report from Maharashtra, India. J Infect Public Health 2015; 8: 502-505.
46. Plamondon K M, Hanson L, Labonte R, Abonyi S. The Global Fund and tuberculosis in Nicaragua: building sustainable capacity? Can J Public Health 2008; 99: 355-358.
47. Posey D L, Marano N, Cetron M S. Cross-border solutions needed to address tuberculosis in migrating populations. Int J Tuberc Lung Dis 2017; 21: 485-486.
48. World Health Organization. A human rights approach to tuberculosis. WHO/CDS/STB/2001.9. Geneva, Switzerland: WHO, 2001. http://www.who.int/hhr/information/A%20Human%20Rights%20Approach%20to%20Tuberculosis.pdf. Accessed April 2017.